Drug Type Small molecule drug |
Synonyms SRT-325 |
Target |
Mechanism HTT gene modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC39H33F4N5O5 |
InChIKeyFDCKDXZISZRERO-UHFFFAOYSA-N |
CAS Registry1394165-15-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Discovery | US | - |